Abstract
Bortezomib, dietary tannic acid and an FDA-approved excipient poloxamer were used as building blocks without any chemical syntheses and modifications to construct a dynamic self-delivery nanodrug with high drug loading, outstanding stability, tunable size and pH-controlled release. This strategy with high druggability, reproducibility and productivity might be desirable and useful for pharmaceutical formulations of bortezomib.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Biocompatible Materials / chemistry
-
Biocompatible Materials / pharmacology
-
Bortezomib / chemistry*
-
Bortezomib / metabolism
-
Cell Survival / drug effects
-
Drug Carriers / chemistry*
-
Drug Liberation
-
Humans
-
Hydrogen-Ion Concentration
-
MCF-7 Cells
-
Nanoparticles / chemistry*
-
Particle Size
-
Poloxamer / chemistry
-
Poloxamer / pharmacology
-
Proteasome Inhibitors / chemistry
-
Proteasome Inhibitors / metabolism
-
Tannins / chemistry
-
Tannins / pharmacology
Substances
-
Biocompatible Materials
-
Drug Carriers
-
Proteasome Inhibitors
-
Tannins
-
Poloxamer
-
Bortezomib